More Data Back Common Drugs as Adjuncts for Cancer

(MedPage Today) — Recurrence after surgery for colorectal cancer (CRC) declined by almost two-thirds in patients who received a short course of a COX2 inhibitor and a beta blocker, a small randomized trial showed.
Patients who received the drugs…

Source link

Related posts

Gene Expression Signature in Surgical Tissues and Endoscopic Biopsies Identifies High-risk T1 Colorectal Cancers


New review provides guidance to address gaps in transgender health care


Boost microbiota studies


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World